Newsletter
Earnings
Interviews
Transcripts
×
Menu
Home
Earnings
Interviews
Transcripts
IPO
Tech
Biotechnology
Transcript
Immunogen Inc (NASDAQ:IMGN) Q4 2019 Earnings Call Transcript
February 14, 2020
Acasti Pharma (ACST): Q3 2020 Earnings Snapshot
February 14, 2020
AbbVie (ABBV) Q4 earnings preview: Generic competition might weigh on results
February 6, 2020
Amgen’s (AMGN) Q4 results beat estimates
January 30, 2020
Biogen (NASDAQ: BIIB): Q4 2019 Earnings Snapshot
January 30, 2020
Pfizer beats Q4 revenue estimates; earnings miss expectations
January 28, 2020
Key factors to note when Pfizer (PFE) reports Q4 earnings results
January 24, 2020
Abbott Laboratories (ABT) reports in-line earnings for Q4; guides FY20
January 22, 2020
Avid Bioservices (NASDAQ: CDMO): Q2 2020 Earnings Snapshot
December 9, 2019
Affimed (AFMD): Q3 2019 Earnings Snapshot
November 19, 2019
Where is Amarin (AMRN) headed after FDA panel favors Vascepa’s label expansion?
November 15, 2019
Bio-Path Holdings, Inc. (NASDAQ: BPTH): Q3 2019 Earnings Snapshot
November 15, 2019
CorMedix, Inc. (NYSE: CRMD): Q3 2019 Earnings Snapshot
November 14, 2019
Amicus Therapeutics (FOLD): Q3 2019 Earnings Snapshot
November 11, 2019
Obalon Therapeutics (NASDAQ: OBLN): Q3 2019 Earnings Snapshot
November 8, 2019
Teva Q3 profit misses estimates, tightens FY19 forecast
November 7, 2019
MannKind (NASDAQ: MNKD): Q3 2019 Earnings Snapshot
November 6, 2019
Cara Therapeutics’ (CARA) loss expands in Q3 on higher costs
November 5, 2019
Viking Therapeutics (VKTX): Q3 2019 Earnings Snapshot
November 5, 2019
Allergan (NYSE: AGN) Q3 loss widens but beats estimates
November 5, 2019
Intercept Pharmaceuticals posts Q3 miss, stock slips
November 5, 2019
Posts pagination
« Previous
1
…
20
21
22
23
24
25
Next »
Top